Indicated for the management of selected, refractory, patients with epilepsy, on stable regimens of anti-epileptic drugs, who require intermittent use of diazepam to control bouts of increased seizure activity

Indicated for the control of absence (petit mal) seizures that are refractory to other drugs

Indicated for the treatment of partial-onset seizures in adults

Indicated for the treatment of partial-onset or primary generalized tonic-clonic seizures, adjunctive therapy for partial-onset, primary generalized tonic-clonic seizures, seizures associated with Lennox-Gastaut syndrome (LGS), and preventive treatment of migraine

Indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome

Indicated for the treatment of partial-onset seizures.

Indicated as an adjunctive therapy for the treatment of partial-onset seizures, this approval is for the first liquid formulation of zonisamide.

A first-time generic for Vimpat, this drug treats partial onset seizures

This is the first time a generic has been approved for Aptiom. For the adjunctive treatment of partial-onset seizures